MPO and metabolic dysfunction-associated steatotic liver disease: In NAFLD/NASH rats we observed a huge increase in MPO expression in liver tissue, which was counteracted by the treatment, suggesting its activity in reducing inflammatory pathways and neutrophil recruitment.